Palvella Therapeutics, Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• AAAditya AsokanDirector
• MCMichael ChristopherDirector
• TDTodd DavisDirector
• JDJohn DouxDirector
• CFCory FreedlandDirector
• KGKathleen GoinExecutive Officer
• THTimothy HenkelDirector
• EHElaine HeronDirector
• GJGeorge JenkinsDirector
• WKWesley KaupinenDirector · Executive Officer
• JMJeffrey MartiniExecutive Officer
• KMKathleen McGowanExecutive Officer
• SMScott MorensteinDirector
• BSBraham Shroot, Ph.D.Executive Officer
• DTDavid TierneyDirector
• TWTadd WesselDirector

• 17 Jul 2025Compositions Of Rapamycin And Their Use In The Treatment Of Microcystic Lymphatic Malformationapplication
• 03 Jul 2025ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEapplication
• 17 Jun 2025ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted
• 08 Apr 2025ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted
• 05 Dec 2024ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEapplication
• 05 Sept 2024Methods And Compositions For Treating Gorlin Syndromeapplication
• 20 Jun 2023ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted
• 13 Apr 2023Anhydrous Compositions Of Egfr Inhibitors And Methods Of Useapplication
• 04 Apr 2023METHODS OF TREATING KERATIN HYPERPROLIFERATION DISORDERS USING mTOR INHIBITORSgranted
• 05 Oct 2021ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted
• 11 May 2021ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted
• 28 Jul 2020ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEgranted

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.